| Product Information |
DR-XY45701_PI_01.pdf
|
| Registration Number |
DR-XY45701
|
| Generic Name |
Budesonide + Formoterol fumarate dihydrate
|
| Brand Name |
Symbicort Rapihaler
|
| Dosage Strength |
160 mcg/4.5 mcg per Actuation
|
| Dosage Form |
Inhalation Aerosol
(Pressurized Suspension for Inhalation)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
Pressurized Metered Dose Inhaler with a
Perfluoroalkoxy (PFA) Polymer Internally Coated Anodised Aluminum Can Sealed with a Retention Type Metering Valve Wrapped in a Foil Pouch with Dessicant Sachet x 120 Actuations (Box of 1's)
|
| Manufacturer |
AstraZeneca Dunkerque Production
|
| Country of Origin |
France
|
| Trader |
|
| Importer |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Distributor |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Application Type |
-
|
| Issuance Date |
28 March 2022
|
| Expiry Date |
09 December 2026
|